View all trials
Showing 56 results

The table can be sorted by “Study title” or “Protocol ID” sorted alphabetically in either Ascending (default) or Descending (on second click) order.
The default sorting is by “Study title” in alphabetical ascending order.

Study titleProtocol IDDisease type(s)Location(s)Eligibility criteriaStatus
 Page 1 of 6, items 1 to 10 of 56.
A Clinical and Molecular Risk-Directed Therapy For Newly Diagnosed Medulloblastoma SJMB12
Brain and Spinal Tumours
Medulloblastoma/PNET
Children's Hospital at WestmeadSydney
Perth Children's HospitalPerth
Queensland Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Starship Children's HospitalAuckland, NZ
Sydney Children's Hospital
External site Open
A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia INTACT-WT1
Leukaemia
AML
Children's Hospital at WestmeadSydney
Open
A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial. CCtl019B2206
Royal Children's Hospital Melbourne
Open
A Phase 1 Study of Intravenous EGFR-ErbituxEDVSMIT (EEDVSMit) in Children with Recurrent / Refractory Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor (EGFR). ECREST
Sydney Children's Hospital
Open
A Phase 1 study of Temozolomide, Irinotecan, and O6BG for Children with Recurrent or Resistant Neuroblastoma. TIO
Solid tumours
Neuroblastoma
Children's Hospital at WestmeadSydney
Open
A Phase I Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects with Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma EZH102
Solid tumours
Children's Hospital at WestmeadSydney
Queensland Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Sydney Children's Hospital
Open
A Phase I, open-label, dose escalation study of LDK378 in pediatric patients with malignancies that have a genetic alteration in anaplastic lympohoma kinase (ALK). CLDK378X2103
Royal Children's Hospital Melbourne
Sydney Children's Hospital
Open
A Phase I/II Study of Pembrolizumab (MK-3475) in Children with advanced melanoma or a PD-L1 positive advanced, relapsed or refractory solid tumor or lymphoma. MSD MK-3475-051
Children's Hospital at WestmeadSydney
Queensland Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Starship Children's HospitalAuckland, NZ
External site Open
A Phase II Study of Panobinostat in Paediatric, Adolescent and Young Adult Patients with Solid Tumours Including Osteosarcoma, Malignant Rhabdoid Tumour/Atypical Teratoid Rhabdoid Tumours and Neuroblastoma NORTH / ACCT008
Brain and Spinal Tumours
ATRT
Solid tumours
Neuroblastoma
Solid tumours
Osteosarcoma
Monash Children's HospitalMelbourne
Starship Children's HospitalAuckland, NZ
External site Open
A phase II, open-labeled, multi-center, randomized controlled trial of Vinblastine +/- Bevacizumab for the treatment of chemotherapy-nai¨ve children with unresectable or progressive low grade glioma OZM-063
Brain and Spinal Tumours
Low Grade Gliomas
Perth Children's HospitalPerth
Queensland Children's HospitalBrisbane
Royal Children's Hospital Melbourne
Starship Children's HospitalAuckland, NZ
Women and Children's HospitalAdelaide
External site Open